iRhythm Technologies Inc at JPMorgan Healthcare Conference Transcript
Okay. Thanks, everyone, for coming today. My name is Allen Gong, here on the JPMorgan Medtech team. I'm really excited to have the management team of iRhythm here today this morning. We're going to start off with some prepared remarks from CEO, Quentin Blackford, and then we're going to tag in Dan Wilson, CFO, for some Q&A after that.
So Quentin, if you could start us off.
Terrific. Can you guys hear me okay? Thanks for having us, Allen. We appreciate the opportunity to be here. We're excited to be here, coming off of an incredible 2025 for iRhythm, and we're looking forward to an even more exciting 2026.
As we look ahead, just a quick reminder, I will be using forward-looking statements during the course of this morning's presentation. I'd refer you to our company website, company filings for any further information that you might be looking for there.
When a signal changes everything, when
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

